Immunogenicity of different hepatitis B virus vaccination schedules in liver transplant recipients

Hepatology Research

Volumn 43, Issue 5, 2013, Pages 495-501

  Feng, Lijuan ^a   Niu, Yujian ^b   Chen, Hong ^b   You, Hong ^a   Zang, Yunjin ^b   Li, Li ^b   Shan, Shan ^b   Tan, Yule ^b   Jia, Jidong ^a   Shen, Zhongyang ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Hepatitis B virus recurrence; Hepatitis B virus vaccine; Liver transplantation

Indexed keywords

ADEFOVIR DIPIVOXIL; ENTECAVIR; HEPATITIS B ANTIBODY; LAMIVUDINE; RECOMBINANT HEPATITIS B VACCINE; TELBIVUDINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; VACCINATION;

EID: 84876952863     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01102.x     Document Type: Article

References (26)

1. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619-626.
2. Chen J, Yi L, Jia JD, Ma H, You H. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review. J Gastroenterol Hepatol 2010; 25: 872-879.
3. Katz LH, Paul M, Guy DG, Tur-Kaspa R. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis. Transpl Infect Dis 2010; 12: 292-308.
4. China Liver Transplant Registry. Annual Scientific Report. China: China Liver Transplant Registry, 2010.
5. Dan YY, Wai CT, Yeoh KG, Lim SG. Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transpl 2006; 12: 736-746.
6. Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001; 8: 237-247.
7. Barcena R, Fernandez-Braso M, Urman J etal. Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis. Transplant Proc 1999; 31: 2459-2460.
8. Bienzle U, Gunther M, Neuhaus R, Neuhaus P. Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: preliminary results. Liver Transpl 2002; 8: 562-564.
9. Sanchez-Fueyo A, Rimola A, Grande L etal. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31: 496-501.
10. Pasricha N, Datta U, Chawla Y etal. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine. BMC Infect Dis 2006; 6: 65.
11. Rosenau J, Hooman N, Hadem J etal. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007; 13: 367-373.
12. Karasu Z, Ozacar T, Akarca U etal. HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence. J Viral Hepat 2005; 12: 212-215.
13. Lo CM, Liu CL, Chan SC, Lau GK, Fan ST. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol 2005; 43: 283-287.
14. Starkel P, Stoffel M, Lerut J, Horsmans Y. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients. Liver Transpl 2005; 11: 1228-1234.
15. Kallinowski B, Benz C, Buchholz L, Stremmel W. Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc 1998; 30: 797-799.
16. Nothdurft HD, Dietrich M, Zuckerman JN etal. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002; 20: 1157-1162.
17. Bosnak M, Dikici B, Bosnak V, Haspolat K. Accelerated hepatitis B vaccination schedule in childhood. Pediatr Int 2002; 44: 663-665.
18. de Vries-Sluijs TE, Hansen BE, van Doornum. GJ etal. A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients. J Infect Dis 2011; 203: 984-991.
19. Weksler ME. Changes in the B-cell repertoire with age. Vaccine 2000; 18: 1624-1628.
20. de Vries-Sluijs TE, Hansen BE, van Doornum GJ etal. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. J Infect Dis 2008; 197: 292-294.
21. Goldwater PN. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997; 15: 353-356.
22. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998; 15: 1-8.
23. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254: 3187-3189.
24. Lo CM, Lau GK, Chan SC, Fan ST, Wong J. Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Am J Transplant 2007; 7: 434-439.
25. Angelico M, Di PD, Trinito MO etal. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002; 35: 176-181.
26. Bienzle U, Gunther M, Neuhaus R etal. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38: 811-819.